Polar Capital Global Healthcare Trust plc (PCGH) - Cash Flow Conversion Efficiency

Latest as of March 2026: -0.003x

Based on the latest financial reports, Polar Capital Global Healthcare Trust plc (PCGH) has a cash flow conversion efficiency ratio of -0.003x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (GBX-1.22 Million ≈ $-147.95 USD) by net assets (GBX377.05 Million ≈ $45.88K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See net asset quality index of Polar Capital Global Healthcare Trust pl to measure how much of total assets are equity-financed.

Polar Capital Global Healthcare Trust plc - Cash Flow Conversion Efficiency Trend (2012–2025)

This chart illustrates how Polar Capital Global Healthcare Trust plc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check earnings quality score of Polar Capital Global Healthcare Trust pl to evaluate the quality of earnings relative to operating cash generation.

Polar Capital Global Healthcare Trust plc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Polar Capital Global Healthcare Trust plc ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
ENDRA Life Sciences Inc
NASDAQ:NDRA
-0.627x
Meihua International Medical Technologies Co. Ltd.
NASDAQ:MHUAF
0.055x
Ashoka India Equity Investment Trust PLC
LSE:AIE
-0.013x
Krakatoa Resources Ltd
AU:KTA
-0.524x
abrdn Asian Income Fund Limited
LSE:AAIF
0.031x
Vanadium Resources Ltd
AU:VR8
-0.009x
Llama Group S.A.
PA:ALLAM
0.411x
JIADE LIMITED Common stock
NASDAQ:JDZG
0.040x

Annual Cash Flow Conversion Efficiency for Polar Capital Global Healthcare Trust plc (2012–2025)

The table below shows the annual cash flow conversion efficiency of Polar Capital Global Healthcare Trust plc from 2012 to 2025. For the full company profile with market capitalisation and key ratios, see market cap of Polar Capital Global Healthcare Trust pl.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-09-30 GBX448.11 Million
≈ $54.52K
GBX-1.43 Million
≈ $-173.87
-0.003x -5192.46%
2024-09-30 GBX479.07 Million
≈ $58.29K
GBX30.00K
≈ $3.65
0.000x +101.15%
2023-09-30 GBX419.18 Million
≈ $51.00K
GBX-2.29 Million
≈ $-278.51
-0.005x +40.95%
2022-12-31 GBX404.83 Million
≈ $49.26K
GBX-3.74 Million
≈ $-455.54
-0.009x 0.00%
2022-09-30 GBX404.83 Million
≈ $49.26K
GBX-3.74 Million
≈ $-455.54
-0.009x -129.82%
2021-12-31 GBX422.19 Million
≈ $51.37K
GBX-1.70 Million
≈ $-206.72
-0.004x +8.64%
2021-09-30 GBX385.73 Million
≈ $46.93K
GBX-1.70 Million
≈ $-206.72
-0.004x -110.89%
2020-12-31 GBX360.54 Million
≈ $43.87K
GBX14.58 Million
≈ $1.77K
0.040x -9.82%
2020-09-30 GBX325.13 Million
≈ $39.56K
GBX14.58 Million
≈ $1.77K
0.045x +1110.61%
2019-09-30 GBX288.45 Million
≈ $35.10K
GBX-1.28 Million
≈ $-155.74
-0.004x -109.19%
2018-09-30 GBX296.26 Million
≈ $36.05K
GBX14.30 Million
≈ $1.74K
0.048x +130.98%
2017-09-30 GBX250.13 Million
≈ $30.43K
GBX-38.99 Million
≈ $-4.74K
-0.156x -452.71%
2016-09-30 GBX247.82 Million
≈ $30.15K
GBX10.95 Million
≈ $1.33K
0.044x +22.77%
2015-09-30 GBX210.44 Million
≈ $25.60K
GBX7.58 Million
≈ $921.66
0.036x +154.94%
2014-09-30 GBX199.96 Million
≈ $24.33K
GBX-13.10 Million
≈ $-1.59K
-0.066x -81.49%
2013-09-30 GBX155.75 Million
≈ $18.95K
GBX-5.62 Million
≈ $-684.16
-0.036x -19.85%
2012-09-30 GBX120.74 Million
≈ $14.69K
GBX-3.64 Million
≈ $-442.52
-0.030x --

About Polar Capital Global Healthcare Trust plc

LSE:PCGH UK Asset Management
Market Cap
$5.31 Million
GBX43.63 Billion GBX
Market Cap Rank
#28424 Global
#466 in UK
Share Price
GBX435.00
Change (1 day)
-0.68%
52-Week Range
GBX322.00 - GBX455.00
All Time High
GBX455.00
About

Polar Capital Global Healthcare Trust plc is a closed ended equity mutual fund launched and managed by Polar Capital LLP. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the healthcare sector, with an emphasis on companies involved in pharmaceuticals, medical services, medical devices, and biotechnology. The fund primarily invests… Read more